Transcat, Inc. is a provider of accredited calibration and laboratory instrument services, and a value-added distributor of professional grade test, measurement, and control instrumentation. The company operates through two segments, Service and Distribution, and focuses on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, and medical device businesses.
| Price | $84.50 |
|---|---|
| Market cap | $790.9M |
| Sector | Industrials |
| Industry | Specialty Business Services |
| Exchange | NASDAQ |
| 52-week range | 50.23-100 |
| Beta | 0.67 |
Explore TRNS's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.